ASVRX
Price
$9.42
Change
-$0.06 (-0.63%)
Updated
Nov 13 closing price
Net Assets
3.98B
ROFCX
Price
$12.47
Change
-$0.34 (-2.65%)
Updated
Nov 13 closing price
Net Assets
1.04B
Interact to see
Advertisement

ASVRX vs ROFCX

Header iconASVRX vs ROFCX Comparison
Open Charts ASVRX vs ROFCXBanner chart's image
American Century Small Cap Value R
Price$9.42
Change-$0.06 (-0.63%)
VolumeN/A
Net Assets3.98B
Royce Small-Cap Opportunity Consult
Price$12.47
Change-$0.34 (-2.65%)
VolumeN/A
Net Assets1.04B
ASVRX vs ROFCX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. ROFCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Buy and ROFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 3.98B vs. ROFCX (1.05B). ASVRX pays higher dividends than ROFCX: ASVRX (0.43) vs ROFCX (0.00). ASVRX was incepted earlier than ROFCX: ASVRX (16 years) vs ROFCX (20 years). ROFCX (2.34) is less costly to investors than ASVRX (1.58). ASVRX is a more actively managed with annual turnover of: 39.00 vs. ROFCX (35.00). ROFCX has a lower initial minimum investment than ASVRX: ROFCX (2000) vs ASVRX (2500). ROFCX annual gain was more profitable for investors over the last year : -1.46 vs. ASVRX (-16.57). ASVRX return over 5 years is better than : 27.62 vs. ROFCX (19.72).
ASVRXROFCXASVRX / ROFCX
Total Expense Ratio1.582.2471%
Annual Report Gross Expense Ratio1.582.3468%
Fund Existence16 years20 years-
Gain YTD-6.2948.101-78%
Front LoadN/AN/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets3.98B1.05B381%
Annual Yield % from dividends0.430.00-
Returns for 1 year-16.57-1.461,134%
Returns for 3 years-0.1911.68-2%
Returns for 5 years27.6219.72140%
Returns for 10 years10.9923.1747%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMDX8.480.95
+12.69%
Insight Molecular Diagnostics Inc
GSBD9.820.11
+1.13%
Goldman Sachs BDC
APO133.580.70
+0.53%
Apollo Global Management
WK93.08-0.23
-0.25%
Workiva
RLYB0.70-0.01
-0.96%
Rallybio Corp